Page 1

Report: Global Pharmaceutical & Biotechnology Outlook 2013: Mature Biotech Category: Healthcare

Insert Image Height - 3.60 Width – 4.98

www.researchonglobalmarkets.com


Report: Global Pharmaceutical & Biotechnology Outlook 2013: Mature Biotech Report Details

• Publish date: 2nd Jan, 2013

• • • • • • • •

Number of slides: 110 Geographic coverage: Global Available format: PDF, CD, Hardcopy Price for Single User License: USD 2,500 Price for Site License: USD 5,000 Price for Global Site License: 7,500 Delivery Time: Within 1 business day Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google Wallet, PayPal www.researchonglobalmarkets.com


Report: Global Pharmaceutical & Biotechnology Outlook 2013: Mature Biotech Report Insights

• Profitable biotech (Mature biotech) and non-profitable biotech companies (Rising stars) have developed innovative drugs for treatment of chronic and non chronic diseases • In the next five years the distinction between mature biotech companies and large global pharma is likely to disappear as investment in R&D and acquisition start delivering and market cap match the large global pharma • Dividend and consolidation could be the future drivers and continue to attract long term investors • Optimism prevails around the future of this sector as a whole which was reflected in the unprecedented rally in shares in 2012 www.researchonglobalmarkets.com


Report: Global Pharmaceutical & Biotechnology Outlook 2013: Mature Biotech Report Insights (Continued)

• This trend is expected to continue in the next five year driven by launch of Innovative drugs catering to unmet needs in Alzheimers, HCV, osteoporosis, RA, Psoriasis, MS, Dyslipidemia, Cystic fibrosis, Cancer and orphan diseases • Drug approvals and label expansion of existing portfolio of launched drugs and data from late stage pipeline drugs should maintain the growth momentum and investors interest • 2012 was recovering from the big acquisitions made in the last five years by this sector but we expect exercising of some restrain for similar large acquisitions as investors would like to see the returns reflected in the top-line and EPS www.researchonglobalmarkets.com


Report: Global Pharmaceutical & Biotechnology Outlook 2013: Mature Biotech Report Insights (Continued)

• However in-licensing of early or mid stage compounds or small acquisitions will continue since the rising stars will keep throwing the bait by taking risks and innovate using novel technology platforms or validating novel targets for treating diseases • Patent expiry impact is modest for the next five years for the sector as majority have not so easy to copy biologics and other drugs in their portfolio • The optimism of biosimilar players is reflected in the maturing pipeline • Para IV filing from other generic players continues to pour leaving room for surprises and volatility www.researchonglobalmarkets.com


Report: Global Pharmaceutical & Biotechnology Outlook 2013: Mature Biotech Report Coverage

• In depth analyses of biotech companies, their launched drug portfolio and promising drug candidates in the pipeline is provided • Current competitive landscape of the targeted therapy areas and the innovative strategy each company is deploying to create or retain its leadership in the therapy areas has been discussed • Forecast for major marketed drugs and drugs in the pipeline are included • Risk reward analyses of important upcoming milestones of the companies are included which should help fund managers as well as pharma company management to make critical decisions

www.researchonglobalmarkets.com


Report: Global Pharmaceutical & Biotechnology Outlook 2013: Mature Biotech Table of Contents

• Macro Analysis • Merger & Acquisitions Forecast (2013-2020) • Industry Tables

www.researchonglobalmarkets.com


Interested in this report? To view more details regarding this premium market research report, Please click here

For further information, get in touch with us: E-mail: support@researchonglobalmarkets.com Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600 About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports Industry Segments Automotive & Transport

Consumer goods

Agriculture

Food and Beverage

Energy and Utilities

Public Sector

Manufacturing & Construction

Healthcare

Media & Entertainment

IT, Telecom & Electronics

Services

Others

www.researchonglobalmarkets.com

Global pharmaceutical and biotechnology outlook mature biotech | research report  

Global Biopharmaceutical Outlook 2013 of the Mature Biotech sector released by MP Advisors provides valuations and an in depth analyses of b...

Read more
Read more
Similar to
Popular now
Just for you